DANIELLE EDDINGS: Open Payments
NPI 1982939740 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 13 payments from 10 companies in 2025. Trend: 2023 $1,383 · 2024 $891 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Dompe US, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: OXERVATE, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, Auvelity, VRAYLAR, Jornay PM, Qelbree.
Industry payments across MO — which companies pay providers there.
